Back
ABN AMRO Bank NV Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
73
AAVMY
ABN AMRO Bank NV
Last Price:
$23.67
Seasonality Move:
-0.03%
Buy
55
RYTM
Rhythm Pharmaceuticals
Last Price:
$60.21
Seasonality Move:
54.9%
Buy
73
ABN AMRO Bank NV (AAVMY)
is a Buy
Is ABN AMRO Bank NV a Buy, Sell or Hold?
-
The current ABN AMRO Bank NV [AAVMY] share price is $23.67. The Score for AAVMY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
AAVMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $60.18. The Score for RYTM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AAVMY Stock Price Chart
What is ABN AMRO Bank NV's stock price today?
-
The ABN AMRO Bank NV share price today is $23.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AAVMY is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $60.18The current trend is relatively stagnant and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
AAVMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.64 | Buy |
Relative Strength Index (14 RSI): | 76.25 | Buy |
Chaikin Money Flow: | -2070 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.17 - 22.07) | Buy |
Bollinger Bands (100): | (16.42 - 21.26) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 50.66 | Buy |
Chaikin Money Flow: | 683641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.79 - 63.99) | Sell |
Bollinger Bands (100): | (52.97 - 60.83) | Buy |
AAVMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.1 | Buy |
20-day SMA: | 21.42 | Buy |
50-day SMA: | 20.97 | Buy |
200-day SMA: | 17.77 | Buy |
8-day EMA: | 22.35 | Buy |
20-day EMA: | 21.6 | Buy |
50-day EMA: | 20.65 | Buy |
200-day EMA: | 18.32 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.83 | Buy |
20-day SMA: | 61.69 | Sell |
50-day SMA: | 57.05 | Buy |
200-day SMA: | 54.4 | Buy |
8-day EMA: | 59.69 | Buy |
20-day EMA: | 60.27 | Sell |
50-day EMA: | 58.68 | Buy |
200-day EMA: | 53.81 | Buy |
ABN AMRO Bank NV Earnings Growth & AAVMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
ABN AMRO Bank NV Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |